webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-Val-Ala-PAB-PNP

  CAS No.: 1394238-92-6   Cat No.: BADC-00943   Purity: >98.0% 4.5  

Fmoc-Val-Ala-PAB-PNP is a peptide-based ADC linker with valine-alanine cleavable sequence, Fmoc protection, and PNP ester for efficient conjugation. Supports selective payload release and stable antibody-drug conjugate synthesis.

Fmoc-Val-Ala-PAB-PNP

Structure of 1394238-92-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C37H36N4O9
Molecular Weight
680.70
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(9H-Fluoren-9-yl)methyl ((S)-3-methyl-1-(((S)-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxobutan-2-yl)carbamate; [4-[[(2S)-2-[[(2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoyl]amino]propanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
IUPAC Name
Canonical SMILES
CC(C)C(C(=O)NC(C)C(=O)NC1=CC=C(C=C1)COC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35
InChI
InChI=1S/C37H36N4O9/c1-22(2)33(40-36(44)48-21-32-30-10-6-4-8-28(30)29-9-5-7-11-31(29)32)35(43)38-23(3)34(42)39-25-14-12-24(13-15-25)20-49-37(45)50-27-18-16-26(17-19-27)41(46)47/h4-19,22-23,32-33H,20-21H2,1-3H3,(H,38,43)(H,39,42)(H,40,44)/t23-,33-/m0/s1
InChIKey
ZJHZWBDLYYJQAV-WYOOIXGGSA-N
Solubility
10 mm in DMSO
Shelf Life
≥ 2 years
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Fmoc-Val-Ala-PAB-PNP is a compound used primarily in biochemical and pharmaceutical research, specifically in peptide synthesis and as a linker in drug delivery systems. Here are some key applications of Fmoc-Val-Ala-PAB-PNP:

Peptide Synthesis: Fmoc-Val-Ala-PAB-PNP is employed in the solid-phase synthesis of peptides, providing a reliable building block for creating longer peptide chains. Its Fmoc protective group ensures stability during synthesis and can be easily removed under mild conditions. This makes it an essential reagent for generating high-purity peptides for research and therapeutic applications.

Targeted Drug Delivery: Fmoc-Val-Ala-PAB-PNP serves as a linker molecule in the development of prodrugs and targeted drug delivery systems. By attaching therapeutic agents to this linker, drugs can be released selectively in target tissues or cells, improving efficacy and reducing side effects. This approach is particularly useful in cancer therapy, where precise drug delivery is crucial.

Enzyme Probes: Researchers use Fmoc-Val-Ala-PAB-PNP as a substrate for enzyme activity studies. The compound can be designed to release a detectable signal upon enzymatic cleavage, allowing scientists to monitor specific enzyme activities in vitro and in vivo. This application is essential for understanding enzyme function and for screening potential enzyme inhibitors.

Bioconjugation: Fmoc-Val-Ala-PAB-PNP is used in bioconjugation techniques to attach peptides or other biomolecules to a variety of surfaces or carriers. This makes it possible to create peptide-functionalized biomaterials and biosensors. Such advancements facilitate the study of protein-protein interactions and the development of diagnostic tools.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-PEG2-Val-Cit-PABA-PNP | N-Succinimidyl 3-maleimidopropionate | Lorvotuzumab mertansine | Polatuzumab vedotin | PC SPDP-NHS carbonate ester | Disitamab vedotin | Fmoc-Val-Ala-PAB-PNP
Send Inquiry
Verification code
Inquiry Basket